Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT05614700

Prostate Reirradiation Toxicity Outcomes Feasibility Study (RO-PIP)

Reirradiation Options for Previously Irradiated Prostate Cancer (RO-PIP): Feasibility Randomised Clinical Trial Investigating Toxicity Outcomes Following Reirradiation With Ultra-hypofractionated External Beam Radiotherapy vs. High Dose Rate Brachytherapy

Sponsor: University of Leeds

Conditions Prostate Cancer Radiotherapy Side Effect

Interventions Brachytherapy Sterotactic Body Radiotherapy

Updated 3 times since 2022 Last updated: Nov 14, 2022 Started: Nov 15, 2022 Primary completion: Nov 15, 2024 Completion: Nov 15, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05614700, this NA trial focuses on Prostate Cancer and Radiotherapy Side Effect and remains actively recruiting participants. Sponsored by University of Leeds, it has been updated 3 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Not Yet Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting NA
Dec 2022 — Jul 2024 [monthly]

Not Yet Recruiting NA

First recorded

Nov 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Leeds

Data source: University of Leeds

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.